This is a snippet of the transcript, sign up to read more.
The most strategic acquisition was Triolab who represented Radiometer, who is in blood gas which is a very good business and similar to a Coca-Cola machine. You place the instruments, sell consumables and get organic growth without doing anything. There is a demographic aspect and the fact that you are making more tests in the periphery and in emergency departments, not only in central labs. That's a perfect piece, so Triolab became the extended arm of Radiometer who is a Danish company. It was easy for them to establish because of their relationship with Triolab, but Triolab was always treated as a Radiometer company. Triolab had Stago, a French company in coagulation that was also big business. The third leg was Koriba from Japan, who acquired a French immunology company. Those three businesses account for 65% of Triolab so it was a very stable business. The founder of Triolab, Göran Brandt, sold the company to Addtech.
This is a snippet of the transcript, sign up to read more.
That came up in the due diligence when we listed AddLife, and Håkan Roos was very concerned because we could list the company then lose half the turnover. I had a good relationship with the CEO of Radiometer and the people from Danaher. We knew it would be difficult for them because it takes several years to get established and they couldn't take it from Denmark. We assessed a low risk for Radiometer to establish themselves. That remains the case today because if they have 45% margin and choose to do the business themselves, the cost of sales would be higher than that because they don't have the critical mass.
This is a snippet of the transcript, sign up to read more.
To keep momentum, you need very good relations with suppliers, always looking for new opportunities in the market. I believe the company lost this momentum which is dangerous because you lose business focus when you become too administrative. To keep this going, you need to push the people working in the company because they are ambassadors and have their antennae in the market. You should have a way of communicating this information to the management of the company because salespeople meet customers and understand their needs.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.